Web Analytics

3 Latest Announced Rounds

  • $1,000,000
    Pre-Seed

    3 Investors

    Technology, Information and Internet
    Jun 27th, 2025
  • $12,000,000
    Series A
    Mental Health Care
    Jun 27th, 2025
  • $8,000,000
    Seed

    2 Investors

    Software Development
    Jun 27th, 2025
$1,962.72M Raised in 58 Funding Rounds in the past 7 Days - View All

Funding Round Profile

NeuroSense Therapeutics

start up
United States - Cambridge, Massachusetts
  • 09/12/2021
  • Unknown
  • $12,000,000

Advancing research, development and therapy for ALS and additional CNS indications.

NeuroSense Therapeutics Ltd. (NASDAQ: NRSN) is a clinical stage Biotech company focusing on the development of a ground-breaking treatment for ALS patients, as well as other neurodegenerative diseases.

Currently in preparations towards a Phase IIb in ALS patients in USA and Israel.


Related People

Alon Ben-NoonCo Founder

Alon Ben-Noon Israel - Herzliyya, Tel Aviv

Life Sciences Executive ; Leading NeuroSense Therapeutics, a Biotech startup which accelerates research, development and therapy for ALS (Amyotrophic Lateral Sclerosis) and additional Neurodegenerative diseases.